Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TFPI | P10646 | 1/20 | 0.47 |
| ▸ | FURIN | P09958 | 2/20 | 0.46 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.45 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.44 |
| ▸ | NPY4R | P50391 | 11/20 | 0.44 |
| ▸ | NPY1R | P25929 | 6/20 | 0.44 |
| ▸ | NPY2R | P49146 | 4/20 | 0.44 |
| ▸ | NPY5R | Q15761 | 4/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30208666 | 0.95 | NPY4R (0.45) | TFPIFURINRXFP1NPY4RNPY1R | |
| SCHEMBL30148473 | 0.95 | FURIN (0.46) | TFPIFURINRXFP1PRSS1NPY4R | |
| SCHEMBL29637607 | 0.94 | NPY4R (0.48) | TFPIFURINRXFP1PRSS1NPY4R | |
| SCHEMBL31277157 | 0.92 | NPY4R (0.47) | FURINNPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL30124571 | 0.90 | NPY4R (0.45) | TFPIFURINNPY4RNPY1RNPY2R | |
| SCHEMBL29678407 | 0.89 | NPY4R (0.47) | NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL30874404 | 0.89 | NPY4R (0.46) | TFPIFURINRXFP1NPY4RNPY1R | |
| SCHEMBL31343254 | 0.88 | TFPI (0.53) | TFPIFURINRXFP1 | |
| SCHEMBL30441875 | 0.86 | NPY4R (0.47) | TFPINPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL30974514 | 0.86 | TFPI (0.54) | TFPIRXFP1NPY4RNPY1RNPY2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025032025-A1 | STABLE GLASSY MATERIAL BASED ON HISTIDINE, ARGININE AND GLUTAMIC ACID AMINO ACIDS | VITROPEP (FR) | 2025-02-13 | — | — | WO | disclosed |
| EP-4103593-A1 | OPHTHALMIC PHARMACEUTICAL COMPOSITION AND USE THEREOF | Ferrer Internacional, S.A. (ES) | 2022-12-21 | — | — | EP | disclosed |